Roth Capital Starts IRadimed Corp (IRMD) at Buy

Go back to Roth Capital Starts IRadimed Corp (IRMD) at Buy

IRADIMED (IRMD) Reports Q2 EPS of $0.13

August 12, 2014 7:27 AM EDT

IRADIMED (NASDAQ: IRMD) reported Q2 EPS of $0.13, versus $0.07 reported last year. Revenue for the quarter came in at $4.7 million, versus $2.8 million reported last year.

For earnings history and earnings-related data on IRADIMED (IRMD) click here.

... More